hemo-organicHemo Organic Ltd.

₹8.52+0.00%

Market Cap

₹0.00 Cr

Stock P/E

0.00

ROCE

0.00%

ROE

0.00%

Book Value

₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Public

Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Hemo Organic Ltd. is significantly underperforming compared to its peers in terms of growth, profitability, and valuation metrics. Companies like Sun Pharmaceutical and Dr. Reddy's Laboratories stand out as sector leaders with strong financials, indicating a stark contrast to Hemo's zero growth and profitability metrics.

Key Points

• Hemo Organic Ltd. has zero revenue growth and profitability metrics, making it a clear underperformer.
• Sun Pharmaceutical Industries Ltd. and Dr. Reddy's Laboratories Ltd. lead in profitability and growth metrics, showing strong EPS and ROE figures.
• Cipla Ltd. stands out as a value pick with low PE and PEG ratios amid solid profitability.

Top Performers

Sun Pharmaceutical Industries Ltd.

Highest revenue growth of 8.42% YoY and strong EPS of 45.55, with solid ROE of 16.13%.

Dr. Reddy's Laboratories Ltd.

Strong profitability with a PE of 15.5, ROE of 21.76%, and high revenue growth of 16.54% YoY.

Cipla Ltd.

Attractive valuation with a PE of 23.73 and PEG of 0.35, alongside solid revenue growth and profitability.

Explore

Watchlists

Command Palette